1
|
Roelofs MJE, Temming AR, Piersma AH, van den Berg M, van Duursen MBM. Conazole fungicides inhibit Leydig cell testosterone secretion and androgen receptor activation in vitro. Toxicol Rep 2014; 1:271-283. [PMID: 28962244 PMCID: PMC5598417 DOI: 10.1016/j.toxrep.2014.05.006] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2014] [Revised: 05/12/2014] [Accepted: 05/12/2014] [Indexed: 11/23/2022] Open
Abstract
Conazole fungicides are widely used in agriculture despite their suspected endocrine disrupting properties. In this study, the potential (anti-)androgenic effects of ten conazoles were assessed and mutually compared with existing data. Effects of cyproconazole (CYPRO), fluconazole (FLUC), flusilazole (FLUS), hexaconazole (HEXA), myconazole (MYC), penconazole (PEN), prochloraz (PRO), tebuconazole (TEBU), triadimefon (TRIA), and triticonazole (TRIT) were examined using murine Leydig (MA-10) cells and human T47D-ARE cells stably transfected with an androgen responsive element and a firefly luciferase reporter gene. Six conazoles caused a decrease in basal testosterone (T) secretion by MA-10 cells varying from 61% up to 12% compared to vehicle-treated control. T secretion was concentration-dependently inhibited after exposure of MA-10 cells to several concentrations of FLUS (IC50 = 12.4 μM) or TEBU (IC50 = 2.4 μM) in combination with LH. The expression of steroidogenic and cholesterol biosynthesis genes was not changed by conazole exposure. Also, there were no changes in reactive oxygen species (ROS) formation that could explain the altered T secretion after exposure to conazoles. Nine conazoles decreased T-induced AR activation (IC50s ranging from 10.7 to 71.5 μM) and effect potencies (REPs) were calculated relative to the known AR antagonist flutamide (FLUT). FLUC had no effect on AR activation by T. FLUS was the most potent (REP = 3.61) and MYC the least potent (REP = 0.03) AR antagonist. All other conazoles had a comparable REP from 0.12 to 0.38. Our results show distinct in vitro anti-androgenic effects of several conazole fungicides arising from two mechanisms: inhibition of T secretion and AR antagonism, suggesting potential testicular toxic effects. These effects warrant further mechanistic investigation and clearly show the need for accurate exposure data in order to perform proper (human) risk assessment of this class of compounds.
Collapse
Key Words
- 17β-HSD3, 17β-hydroxysteroid dehydrogenase type 3
- 3β-HSD1, 3β-hydroxysteroid dehydrogenase type 1
- AR, androgen receptor
- Androgen receptor (AR)
- BMR, benchmark response
- CHO cells, Chinese hamster ovary cells
- CYP19, cytochrome P450 enzyme 19 (aromatase)
- CYP51, cytochrome P450 enzyme 51/lanosterol 14α-demethylase
- CYPRO, cyproconazole
- Conazole fungicides
- Cyp11A1, cytochrome P450 enzyme 11A
- Cyp17, cytochrome P450 enzyme 17
- Cyproconazole (PubChem CID: 86132)
- DMEM, Dulbecco's Modified Eagle Medium
- EC50, half maximal effective concentration
- EDCs, endocrine disrupting chemicals
- Endocrine disrupting chemicals (EDCs)
- FLUC, fluconazole
- FLUS, flusilazole
- FLUT, flutamide
- FP, forward primer
- FSH(R), follicle-stimulating hormone (receptor)
- Fluconazole (PubChem CID: 3365)
- Flusilazole (PubChem CID: 73675)
- H295R, human adrenocortical carcinoma cells
- HEXA, hexaconazole
- HMG-CoA red, HMG-CoA reductase
- HSD(s), hydroxysteroid dehydrogenase(s)
- Hexaconazole (PubChem CID: 66461)
- IC50, half maximal inhibitory concentration
- LH(R), luteinizing hormone (receptor)
- MA-10 Leydig cells
- MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- MYC, myclobutanil
- Myclobutanil (PubChem CID: 6336)
- NCBI, National Center for Biotechnology Information
- PBS, phosphate-buffered saline
- PEN, penconazole
- PRO, prochloraz
- Penconazole (PubChem CID: 91693)
- Por, cytochrome P450 oxidoreductase
- Prochloraz (PubChem CID: 73665)
- REP, relative effect potency
- RIA, radioimmunoassay
- ROS, reactive oxygen species
- RP, reverse primer
- RT-qPCR, real time quantitative polymerase chain reaction
- Spermatogenesis
- StAR, steroidogenic acute regulatory protein
- T, testosterone
- TEBU, tebuconazole
- TRIA, triadimefon
- TRIT, triticonazole
- Tebuconazole (PubChem CID: 86102)
- Testosterone (T)
- Triadimefon (PubChem CID: 39385)
- Triticonazole (PubChem CID: 6537961)
- cAMP, 8-bromoadenosine 3′,5′-cyclic monophosphate
Collapse
Affiliation(s)
- Maarke J E Roelofs
- Endocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands.,Center for Health Protection, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands
| | - A Roberto Temming
- Endocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands
| | - Aldert H Piersma
- Center for Health Protection, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands.,Endocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands
| | - Martin van den Berg
- Endocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands
| | - Majorie B M van Duursen
- Endocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands
| |
Collapse
|